CAR T-Cell Therapy | FAQ with Dr. Patrick Brown
CAR T-cell therapy can be a last hope for some pediatric patients and their families.
Patrick Brown, director of the Pediatric Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins explains the excitement about this new therapy, which patients are the best candidates, as well as CAR T-cell effectiveness, safety, and costs.
